MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Balance Sheets Overview

Current Ratio
1022.07%
Cash Ratio
141.91%
Debt to Asset Ratio
7.43%
Unit: Thousand (K) dollars
Assets Breakdown
    • Total current assets
    • Marketable securities
    • Operating lease assets
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Treasury stock, at cost (16,216,...
    • Accumulated deficit
    • Others
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash and cash equivalents
99,647
113,600
89,130
92,710
Marketable securities
517,929
623,438
765,295
860,150
Accounts receivable, net
20,112
-
-
-
Inventory
30,152
-
-
-
Contract assets
4,104
16,132
10,577
5,029
Inventory
-
35,087
32,920
32,034
Prepaid expenses and other current assets
45,724
46,586
44,130
43,186
Total current assets
717,668
834,843
942,052
1,033,109
Marketable securities
347,254
308,454
310,013
304,341
Operating lease assets
23,875
27,196
30,454
33,650
Property and equipment, net
9,946
10,566
10,775
10,675
Other non-current assets
9,681
3,931
3,931
3,930
Total assets
1,108,424
1,184,990
1,297,225
1,385,705
Accounts payable
16,345
13,747
18,355
19,553
Accrued expenses
34,647
26,293
45,459
37,217
Income taxes payable
-
-
0
0
Operating lease liabilities
19,225
18,805
18,392
17,987
Total current liabilities
70,217
58,845
82,206
74,757
Operating lease liabilities, net of current portion
11,946
16,940
21,815
26,528
Other non-current liabilities
240
90
90
90
Total liabilities
82,403
75,875
104,111
101,375
Common stock, 0.001 par value 125,000,000 shares authorized 75,821,241 shares issued and 59,604,830 outstanding at june30, 2026, and 74,665,003 shares issued and 58,448,592 outstanding at december31, 2025
76
76
75
74
Additional paid-in capital
2,591,745
2,572,655
2,555,037
2,538,357
Accumulated other comprehensive (loss) income
-1,795
-314
2,193
2,051
Accumulated deficit
-761,519
-660,816
-561,705
-453,666
Treasury stock, at cost (16,216,411 shares at june30, 2026 and december31, 2025)
802,486
802,486
802,486
802,486
Total stockholders equity
1,026,021
1,109,115
1,193,114
1,284,330
Total liabilities and stockholders equity
1,108,424
1,184,990
1,297,225
1,385,705
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Marketable securities$517,929K (-39.64%↓ Y/Y)Cash and cashequivalents$99,647K (23.22%↑ Y/Y)Prepaid expenses andother current assets$45,724K (2.31%↑ Y/Y)Inventory$30,152K (-2.26%↓ Y/Y)Accounts receivable, net$20,112K (303.37%↑ Y/Y)Contract assets$4,104K (-17.69%↓ Y/Y)Total current assets$717,668K (-29.60%↓ Y/Y)Marketable securities$347,254K (-13.29%↓ Y/Y)Operating lease assets$23,875K (-35.10%↓ Y/Y)Property and equipment,net$9,946K (-5.98%↓ Y/Y)Other non-currentassets$9,681K (145.59%↑ Y/Y)Total assets$1,108,424K (-24.66%↓ Y/Y)Total liabilities andstockholders equity$1,108,424K (-24.66%↓ Y/Y)Total stockholdersequity$1,026,021K (-25.08%↓ Y/Y)Total liabilities$82,403K (-18.96%↓ Y/Y)Treasury stock, at cost(16,216,411 shares at...$802,486K (0.00%↑ Y/Y)Accumulated deficit-$761,519K (-117.43%↓ Y/Y)Accumulated othercomprehensive (loss) income-$1,795K (-374.05%↓ Y/Y)Additional paid-in capital$2,591,745K (2.78%↑ Y/Y)Total currentliabilities$70,217K (-0.27%↓ Y/Y)Operating leaseliabilities, net of current...$11,946K (-61.68%↓ Y/Y)Other non-currentliabilities$240K (137.62%↑ Y/Y)Common stock, 0.001 parvalue 125,000,000...$76K (2.70%↑ Y/Y)Accrued expenses$34,647K (-1.82%↓ Y/Y)Operating leaseliabilities$19,225K (9.30%↑ Y/Y)Accounts payable$16,345K (-6.77%↓ Y/Y)

AGIOS PHARMACEUTICALS, INC. (AGIO)

AGIOS PHARMACEUTICALS, INC. (AGIO)